NovaSterilis
PrivateLast Round
Grant
Feb 1, 2024
Total Funding Raised
$7.39M
Company Overview
NovaSterilis is a biotechnology company that develops and manufactures supercritical carbon dioxide (scCO2) sterilization and decellularization technology platforms for the regenerative medicine, medical device, and pharmaceutical industries.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Medical Devices, Biotechnology, Clean Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NovaSterilis Comparables
Compare NovaSterilis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Noxilizer | 83% | |
| Andersen Sterilizers, Inc. | 74% | |
| De Lama S.p.A. | 69% |
NovaSterilis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 1, 2024 | ||||
| Grant | Sep 20, 2022 | ||||
| Grant | Jan 18, 2017 | ||||
| Grant | Feb 1, 2015 | ||||
| Grant | Sep 1, 2012 | ||||
Grant | Sep 15, 2011 |
NovaSterilis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| NIH RADx | Grant |
| Big Red Ventures | Seed |
| National Institutes of Health (NIH) | Grant |
| National Institute of General Medical Sciences | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 7, 2025
Presenting at the 34th Annual Conference of the European Society for Biomaterials.
- Feb 1, 2024
$1.75M grant from National Institute of Allergy and Infectious Diseases.
NovaSterilis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NovaSterilis's valuation, stock price, and market status.
Is NovaSterilis a public or private company?
NovaSterilis is a private company.
What is the current stock price of NovaSterilis?
NovaSterilis is a private company with no public stock price. No recent secondary market data is available.
How much is NovaSterilis worth (valuation)?
Valuation information for NovaSterilis is not publicly available.
Can I buy NovaSterilis stock?
NovaSterilis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NovaSterilis's last funding round?
NovaSterilis's most recent funding round was Grant on February 23, 2024.
Who are the main investors in NovaSterilis?
Key investors in NovaSterilis include National Institute of Allergy and Infectious Diseases, NIH RADx, National Institute of General Medical Sciences.
Will NovaSterilis IPO soon?
No public IPO plans have been announced for NovaSterilis.
How can I track NovaSterilis secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NovaSterilis's secondary market activity and sign up for updates.